Skip to main content
. 2019 Dec 3;87(2):176–185. doi: 10.1093/neuros/nyz495

TABLE 4.

Medication Change Following the 10-kHz SCS Therapy

3 mo 6 mo 12 mo
Increased 8.6% (3) 11.4% (4) 6.7% (2)
No change 80.0% (28) 65.7% (23) 63.3% (19)
Reduced or eliminated 11.4% (4) 22.8% (8) 30.0% (9)